Day 2, Thursday 3 June 2010

07:30 Registration and Breakfast

Technology Convergence: drivers, enablers, barriers and challenges.

09:00 This session will explore the business models surrounding convergence of technologies relating to therapeutics and diagnostics. Speakers will consider the drivers of convergence, possible barriers and how the pathways to convergence are likely to be managed towards the over-arching objective of routine application for patient benefit.

Chaired by Nigel Job, CEO, Remtec Search and Selection Ltd

Session speakers

• Dr Stephen Little, Vice President, Personalised Healthcare Qiagen
• Crispin Simon, CEO, Biocompatibles
• Simon McGuire General Director, Philips Respironics Respiratory Drug Delivery
• Mike Fisher Business Development Director, Bio Nano Consulting

10:30  Morning Refreshments

Drug Delivery

11:10 This session will examine future technology trends in drug delivery, looking at both formulation and devices for injected, inhaled and transdermal applications.

Chaired by Dr Iain Simpson, Head of Drug Delivery, Sagentia

Session speakers:

• Dr Jan Jezek, Chief Scientific Officer, Arecor Limited
• Nic Bowman, Director Device Design and Development, Pfizer John Hart ERBI Future trends in inhalation devices
• Dr Ryan Donnelly, Senior Lecturer in Pharmaceutics, Queens University, Belfast
• Dr Philip Green, Senior Director, Drug Delivery Devices, Merck & Co Phil Green UK conference presentation Final

12:30  Lunch

Stratified Medicine Discussion Forum (working lunch in the James Watson Room)

12:30 This lunchtime round table session is an opportunity for those with an interest in stratified medicine to explore the economic value of business-to-business partnerships and deal structures. The relative contributions of the various stakeholders will be explored, along with how best to engage the regulators and payers with the agenda of stratified medicine.

Keynote Speaker Session

14:00  Professor Nina Fedoroff, Science and Technology Adviser to the U.S. Secretary of State

And So To The Future…

14:30 Speakers will take a forwards look at a range of mechanisms underpinning new innovation and the development and adoption of new technologies, as well as likely global regulatory and funding structures.

Chaired by Ted Agne, President, Communications Strategy Group

Session speakers:

• Dr Thomas Okarma, President & CEO, Geron Corporation Dr Okarma's slide Odessy Slide
• Dr Louise Wood, Head of Innovation and Industry R & D Relations, Department of Health
• Dr Jackie Hunter, Director, Pharmivation
• Dr Guy Brown, Senior Lecturer in the Department of Biochemistry, University of Cambridge GuyBrown

16:00 Closing keynote address

• Professor Mike Stratton, Director of the Wellcome Trust Sanger Institute

16:30 Networking drinks reception & tours of the Sanger Institute Sequencing Centre